| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.3M | — | +62.0% |
| Cost of Revenue | $3.8M | — | +43.8% |
| R&D Expense | $21.5M | — | -11.5% |
| SG&A Expense | $23.1M | — | -11.2% |
| Operating Income | -$36.2M | — | +20.4% |
| Interest Expense | $2.2M | — | +1.7% |
| Pre-tax Income | -$36.9M | — | +22.1% |
| Net Income | -$38.3M | — | +32.2% |
| EPS (Basic) | -$0.28 | — | +42.9% |
| EPS (Diluted) | -$0.28 | — | +42.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $115.2M | +29.7% | +39.8% |
| Short-term Investments | $51.8M | -37.8% | — |
| Accounts Receivable | $22.1M | +23.9% | -63.5% |
| Inventory | $4.8M | +52.1% | +37.2% |
| Current Assets | $206.0M | -0.3% | -33.6% |
| Total Assets | $266.0M | +3.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$57.9M | — | -124.1% |
| Investing Cash Flow | $30.7M | — | +275.3% |
| Financing Cash Flow | $53.6M | — | — |
| -28.3% |
| Current Liabilities | $132.3M | -5.7% | -48.1% |
| Total Liabilities | $187.4M | -5.0% | -66.2% |
| Stockholders' Equity | $78.6M | +28.9% | +142.9% |